Large intervening non-coding RNA HOTAIR is an indicator of poor prognosis and a therapeutic target in human cancers

International Journal of Molecular Sciences

Volumn 15, Issue 10, 2014, Pages 18985-18999

  Yao, Yanlan ^a   Li, Jinming ^a   Wang, Lunan ^a  

^a BEIJING HOSPITAL   (China)

Author keywords

HOTAIR; Lncrna; Polycomb repressive complex 2; Prognosis; Therapeutic target

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 2; BRCA1 PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN RECEPTOR; GELATINASE B; HOX TRANSCRIPT ANTISENSE INTERGENIC RNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LONG UNTRANSLATED RNA; LYSINE SPECIFIC DEMETHYLASE 1; MICRORNA; MICRORNA 10B; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; POLYCOMB REPRESSIVE COMPLEX 2; PROTEIN P53; TRANSCRIPTION FACTOR EZH2; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN; WNT PROTEIN; HOTAIR LONG UNTRANSLATED RNA, HUMAN;

ALTERNATIVE RNA SPLICING; BREAST CANCER; CANCER GROWTH; CANCER PROGNOSIS; CANCER THERAPY; CARCINOGENESIS; CELL DIFFERENTIATION; CHROMATIN ASSEMBLY AND DISASSEMBLY; COLORECTAL CANCER; DNA DEGRADATION; DNA METHYLATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE SILENCING; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; METASTASIS; NEOPLASM; PROTEIN PHOSPHORYLATION; PROTEIN RNA BINDING; REVIEW; RNA HYBRIDIZATION; TUMOR SUPPRESSOR GENE; ANIMAL; GENETICS; METABOLISM; MOLECULARLY TARGETED THERAPY; NEOPLASMS; PROGNOSIS;

ANIMALS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MOLECULAR TARGETED THERAPY; NEOPLASMS; PROGNOSIS; RNA, LONG NONCODING;

EID: 84934303353     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms151018985     Document Type: Review

References (51)

1. International Human Genome Sequencing Consortium. Finishing the euchromatic sequence of the human genome. Nature 2004, 431, 931-945.
2. Gutschner, T.; Diederichs, S. The hallmarks of cancer: A long non-coding rna point of view. RNA Biol. 2012, 9, 703-719.
3. Ponting, C.P.; Oliver, P.L.; Reik, W. Evolution and functions of long noncoding rnas. Cell 2009, 136, 629-641.
4. Rinn, J.L.; Kertesz, M.; Wang, J.K.; Squazzo, S.L.; Xu, X.; Brugmann, S.A.; Goodnough, L.H.; Helms, J.A.; Farnham, P.J.; Segal, E., et al. Functional demarcation of active and silent chromatin domains in human hox loci by noncoding rnas. Cell 2007, 129, 1311-1323.
5. Tano, K.; Mizuno, R.; Okada, T.; Rakwal, R.; Shibato, J.; Masuo, Y.; Ijiri, K.; Akimitsu, N. Malat-1 enhances cell motility of lung adenocarcinoma cells by influencing the expression of motility-related genes. FEBS Lett. 2010, 584, 4575-4580.
6. Xu, C.; Yang, M.; Tian, J.; Wang, X.; Li, Z. Malat-1: A long non-coding rna and its important 3' end functional motif in colorectal cancer metastasis. Int. J. Oncol. 2011, 39, 169-175.
7. Ji, Q.; Liu, X.; Fu, X.; Zhang, L.; Sui, H.; Zhou, L.; Sun, J.; Cai, J.; Qin, J.; Ren, J., et al. Resveratrol inhibits invasion and metastasis of colorectal cancer cells via malat1 mediated wnt/beta-catenin signal pathway. PLoS One 2013, 8, e78700.
8. Lai, M.C.; Yang, Z.; Zhou, L.; Zhu, Q.Q.; Xie, H.Y.; Zhang, F.; Wu, L.M.; Chen, L.M.; Zheng, S.S. Long non-coding rna malat-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation. Med. Oncol. 2012, 29, 1810-1816.
9. Lin, R.; Maeda, S.; Liu, C.; Karin, M.; Edgington, T.S. A large noncoding rna is a marker for murine hepatocellular carcinomas and a spectrum of human carcinomas. Oncogene 2007, 26, 851-858.
10. Yang, L.; Lin, C.; Liu, W.; Zhang, J.; Ohgi, K.A.; Grinstein, J.D.; Dorrestein, P.C.; Rosenfeld, M.G. Ncrna-and pc2 methylation-dependent gene relocation between nuclear structures mediates gene activation programs. Cell 2011, 147, 773-788.
11. Gupta, R.A.; Shah, N.; Wang, K.C.; Kim, J.; Horlings, H.M.; Wong, D.J.; Tsai, M.-C.; Hung, T.; Argani, P.; Rinn, J.L. Long non-coding rna hotair reprograms chromatin state to promote cancer metastasis. Nature 2010, 464, 1071-1076.
12. Ishibashi, M.; Kogo, R.; Shibata, K.; Sawada, G.; Takahashi, Y.; Kurashige, J.; Akiyoshi, S.; Sasaki, S.; Iwaya, T.; Sudo, T., et al. Clinical significance of the expression of long non-coding rna hotair in primary hepatocellular carcinoma. Oncol. Rep. 2013, 29, 946-950.
13. Kogo, R.; Shimamura, T.; Mimori, K.; Kawahara, K.; Imoto, S.; Sudo, T.; Tanaka, F.; Shibata, K.; Suzuki, A.; Komune, S. Long noncoding rna hotair regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers. Cancer Res. 2011, 71, 6320-6326.
14. Nie, Y.; Liu, X.; Qu, S.; Song, E.; Zou, H.; Gong, C. Long non-coding rna hotair is an independent prognostic marker for nasopharyngeal carcinoma progression and survival. Cancer Sci. 2013, 104, 458-464.
15. Sorensen, K.P.; Thomassen, M.; Tan, Q.; Bak, M.; Cold, S.; Burton, M.; Larsen, M.J.; Kruse, T.A. Long non-coding rna hotair is an independent prognostic marker of metastasis in estrogen receptor-positive primary breast cancer. Breast Cancer Res. Treat. 2013, 142, 529-536.
16. Chen, F.J.; Sun, M.; Li, S.Q.; Wu, Q.Q.; Ji, L.; Liu, Z.L.; Zhou, G.Z.; Cao, G.; Jin, L.; Xie, H.W., et al. Upregulation of the long non-coding rna hotair promotes esophageal squamous cell carcinoma metastasis and poor prognosis. Mol. Carcinog. 2013, 52, 908-915.
17. Endo, H.; Shiroki, T.; Nakagawa, T.; Yokoyama, M.; Tamai, K.; Yamanami, H.; Fujiya, T.; Sato, I.; Yamaguchi, K.; Tanaka, N. Enhanced expression of long non-coding rna hotair is associated with the development of gastric cancer. PLoS One 2013, 8, e77070.
18. Hajjari, M.; Behmanesh, M.; Sadeghizadeh, M.; Zeinoddini, M. Up-regulation of hotair long non-coding RNA in human gastric adenocarcinoma tissues. Med. Oncol. 2013, 30, 670.
19. Kim, K.; Jutooru, I.; Chadalapaka, G.; Johnson, G.; Frank, J.; Burghardt, R.; Kim, S.; Safe, S. Hotair is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer. Oncogene 2013, 32, 1616-1625.
20. Zhang, J.X.; Han, L.; Bao, Z.S.; Wang, Y.Y.; Chen, L.Y.; Yan, W.; Yu, S.Z.; Pu, P.Y.; Liu, N.; You, Y.P., et al. Hotair, a cell cycle-associated long noncoding RNA and a strong predictor of survival, is preferentially expressed in classical and mesenchymal glioma. Neuro Oncol. 2013, 15, 1595-1603.
21. Zhang, J.; Zhang, P.; Wang, L.; Piao, H.L.; Ma, L. Long non-coding RNA hotair in carcinogenesis and metastasis. Acta Biochim. Biophys. Sin. 2014, 46, 1-5.
22. Panzitt, K.; Tschernatsch, M.M.; Guelly, C.; Moustafa, T.; Stradner, M.; Strohmaier, H.M.; Buck, C.R.; Denk, H.; Schroeder, R.; Trauner, M., et al. Characterization of hulc, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA. Gastroenterology 2007, 132, 330-342.
23. Matouk, I.J.; Abbasi, I.; Hochberg, A.; Galun, E.; Dweik, H.; Akkawi, M. Highly upregulated in liver cancer noncoding RNA is overexpressed in hepatic colorectal metastasis. Eur. J. Gastroenterol. Hepatol. 2009, 21, 688-692.
24. Wang, J.; Liu, X.; Wu, H.; Ni, P.; Gu, Z.; Qiao, Y.; Chen, N.; Sun, F.; Fan, Q. Creb up-regulates long non-coding RNA, hulc expression through interaction with microrna-372 in liver cancer. Nucleic Acids Res. 2010, 38, 5366-5383.
25. Matouk, I.J.; DeGroot, N.; Mezan, S.; Ayesh, S.; Abu-lail, R.; Hochberg, A.; Galun, E. The h19 non-coding RNA is essential for human tumor growth. PLoS One 2007, 2, e845.
26. Pasmant, E.; Laurendeau, I.; Heron, D.; Vidaud, M.; Vidaud, D.; Bieche, I. Characterization of a germ-line deletion, including the entire ink4/arf locus, in a melanoma-neural system tumor family: Identification of anril, an antisense noncoding RNA whose expression coclusters with arf. Cancer Res. 2007, 67, 3963-3969.
27. Turnbull, C.; Ahmed, S.; Morrison, J.; Pernet, D.; Renwick, A.; Maranian, M.; Seal, S.; Ghoussaini, M.; Hines, S.; Healey, C.S., et al. Genome-wide association study identifies five new breast cancer susceptibility loci. Nat. Genet. 2010, 42, 504-507.
28. Yap, K.L.; Li, S.; Munoz-Cabello, A.M.; Raguz, S.; Zeng, L.; Mujtaba, S.; Gil, J.; Walsh, M.J.; Zhou, M.M. Molecular interplay of the noncoding rna anril and methylated histone h3 lysine 27 by polycomb cbx7 in transcriptional silencing of ink4a. Mol. Cell 2010, 38, 662-674.
29. Kotake, Y.; Nakagawa, T.; Kitagawa, K.; Suzuki, S.; Liu, N.; Kitagawa, M.; Xiong, Y. Long non-coding RNA anril is required for the prc2 recruitment to and silencing of p15(ink4b) tumor suppressor gene. Oncogene 2011, 30, 1956-1962.
30. Tsai, M.C.; Manor, O.; Wan, Y.; Mosammaparast, N.; Wang, J.K.; Lan, F.; Shi, Y.; Segal, E.; Chang, H.Y. Long noncoding RNA as modular scaffold of histone modification complexes. Science 2010, 329, 689-693.
31. Yang, Z.; Zhou, L.; Wu, L.M.; Lai, M.C.; Xie, H.Y.; Zhang, F.; Zheng, S.S. Overexpression of long non-coding RNA hotair predicts tumor recurrence in hepatocellular carcinoma patients following liver transplantation. Ann. Surg. Oncol. 2011, 18, 1243-1250.
32. Tano, K.; Akimitsu, N. Long non-coding RNAs in cancer progression. Front. Genet. 2012, 3, 219.
33. He, S.; Liu, S.; Zhu, H. The sequence, structure and evolutionary features of hotair in mammals. BMC Evolut. Biol. 2011, 11, 102.
34. Kaneko, S.; Li, G.; Son, J.; Xu, C.F.; Margueron, R.; Neubert, T.A.; Reinberg, D. Phosphorylation of the prc2 component ezh2 is cell cycle-regulated and up-regulates its binding to ncrna. Genes Dev. 2010, 24, 2615-2620.
35. Schorderet, P.; Duboule, D. Structural and functional differences in the long non-coding RNA hotair in mouse and human. PLoS Genet. 2011, 7, e1002071.
36. Chiyomaru, T.; Yamamura, S.; Fukuhara, S.; Yoshino, H.; Kinoshita, T.; Majid, S.; Saini, S.; Chang, I.; Tanaka, Y.; Enokida, H., et al. Genistein inhibits prostate cancer cell growth by targeting mir-34a and oncogenic hotair. PLoS One 2013, 8, e70372.
37. Xu, Z.Y.; Yu, Q.M.; Du, Y.A.; Yang, L.T.; Dong, R.Z.; Huang, L.; Yu, P.F.; Cheng, X.D. Knockdown of long non-coding RNA hotair suppresses tumor invasion and reverses epithelial-mesenchymal transition in gastric cancer. Int. J. Biol. Sci. 2013, 9, 587-597.
38. Padua Alves, C.; Fonseca, A.S.; Muys, B.R.; de Barros, E.L.B.R.; Burger, M.C.; de Souza, J.E.; Valente, V.; Zago, M.A.; Silva, W.A., Jr. Brief report: The lincrna hotair is required for epithelialto-mesenchymal transition and stemness maintenance of cancer cells lines. Stem Cells 2013, 31, 2827-2832.
39. Jalali, S.; Bhartiya, D.; Lalwani, M.K.; Sivasubbu, S.; Scaria, V. Systematic transcriptome wide analysis of lncrna-mirna interactions. PLoS One 2013, 8, e53823.
40. Wang, L.; Zeng, X.; Chen, S.; Ding, L.; Zhong, J.; Zhao, J.C.; Wang, L.; Sarver, A.; Koller, A.; Zhi, J., et al. Brca1 is a negative modulator of the prc2 complex. EMBO J. 2013, 32, 1584-1597.
41. Lu, L.; Zhu, G.; Zhang, C.; Deng, Q.; Katsaros, D.; Mayne, S.T.; Risch, H.A.; Mu, L.; Canuto, E.M.; Gregori, G., et al. Association of large noncoding RNA hotair expression and its downstream intergenic cpg island methylation with survival in breast cancer. Breast Cancer Res. Treat. 2012, 136, 875-883.
42. Bhan, A.; Hussain, I.; Ansari, K.I.; Kasiri, S.; Bashyal, A.; Mandal, S.S. Antisense transcript long noncoding RNA (lncrna) hotair is transcriptionally induced by estradiol. J. Mol. Biol. 2013, 425, 3707-3722.
43. Svoboda, M.; Slyskova, J.; Schneiderova, M.; Makovicky, P.; Bielik, L.; Levy, M.; Lipska, L.; Hemmelova, B.; Kala, Z.; Protivankova, M., et al. Hotair long non-coding RNA is a negative prognostic factor not only in primary tumors, but also in the blood of colorectal cancer patients. Carcinogenesis 2014, 35, 1510-1515.
44. Liu, X.H.; Sun, M.; Nie, F.Q.; Ge, Y.B.; Zhang, E.B.; Yin, D.D.; Kong, R.; Xia, R.; Lu, K.H.; Li, J.H., et al. Lnc RNA hotair functions as a competing endogenous rna to regulate her2 expression by sponging mir-331-3p in gastric cancer. Mol. Cancer 2014, 13, 92.
45. Lee, N.K.; Lee, J.H.; Park, C.H.; Yu, D.; Lee, Y.C.; Cheong, J.H.; Noh, S.H.; Lee, S.K. Long non-coding RNA hotair promotes carcinogenesis and invasion of gastric adenocarcinoma. Biochem. Biophys. Res. Commun. 2014, 451, 171-178.
46. Geng, Y.J.; Xie, S.L.; Li, Q.; Ma, J.; Wang, G.Y. Large intervening non-coding rna hotair is associated with hepatocellular carcinoma progression. J. Int. Med. Res. 2011, 39, 2119-2128.
47. Ding, C.; Cheng, S.; Yang, Z.; Lv, Z.; Xiao, H.; Du, C.; Peng, C.; Xie, H.; Zhou, L.; Wu, J., et al. Long non-coding RNA hotair promotes cell migration and invasion via down-regulation of RNA binding motif protein 38 in hepatocellular carcinoma cells. Int. J. Mol. Sci. 2014, 15, 4060-4076.
48. Liu, X.H.; Liu, Z.L.; Sun, M.; Liu, J.; Wang, Z.X.; De, W. The long non-coding RNA hotair indicates a poor prognosis and promotes metastasis in non-small cell lung cancer. BMC Cancer 2013, 13, 464.
49. Liu, Z.; Sun, M.; Lu, K.; Liu, J.; Zhang, M.; Wu, W.; De, W.; Wang, Z.; Wang, R. The long noncoding rna hotair contributes to cisplatin resistance of human lung adenocarcinoma cells via downregualtion of p21(waf1/cip1) expression. PLoS One 2013, 8, e77293.
50. Li, D.; Feng, J.; Wu, T.; Wang, Y.; Sun, Y.; Ren, J.; Liu, M. Long intergenic noncoding RNA hotair is overexpressed and regulates pten methylation in laryngeal squamous cell carcinoma. Am. J. Pathol. 2013, 182, 64-70.
51. Niinuma, T.; Suzuki, H.; Nojima, M.; Nosho, K.; Yamamoto, H.; Takamaru, H.; Yamamoto, E.; Maruyama, R.; Nobuoka, T.; Miyazaki, Y., et al. Upregulation of mir-196a and hotair drive malignant character in gastrointestinal stromal tumors. Cancer Res. 2012, 72, 1126-1136.